Get In Touch

Asia Pacific Biologics Contract Manufacturing Market to Surpass Valuation of US$ 9.8 Bn by 2031: Transparency Market Research

Asia Pacific Biologics Contract Manufacturing Market: Introduction

The report provides key insights on the biologics contract manufacturing market in Asia Pacific. The biologics contract manufacturing market in Asia Pacific is projected to expand at a CAGR of 14.5% during the forecast period.

Contract manufacturing is a type of outsourcing, in which a company enters into an agreement or legal settlement with another manufacturing firm for products, parts, or components that the latter will then use in its manufacturing process to complete its product. Biologics contract manufacturing includes the production of biopharmaceutical molecules, proteins, nucleic acids, blood components, and vaccines derived from biological sources. These companies specialize in molecule production and provide various services such as development process, analytical, and quality control.

Asia Pacific Biologics Contract Manufacturing Market Dynamics

Countries in Asia have emerged as desirable outsourcing destinations for the biopharmaceutical industry. Low manufacturing and operating costs in China and India are the key drivers of the biologics contract manufacturing market in the Asia Pacific region. Low labor wages enable pharmaceutical companies in China to reduce manufacturing costs by 30% to 35%. Moreover, favorable tax incentives and an undervalued currency are anticipated to drive the market during the forecast period. The growth of the biopharmaceutical industry in China and India is expected to augment the market in the region.

Asia Pacific Biologics Contract Manufacturing Market: Key Players

Major players operating in the biologics contract manufacturing market in Asia Pacific are Lonza Group, Samsung Biologics Co., Ltd., Patheon by Thermo Fisher Scientific, Inc., Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim, Recipharm Pharmaceuticals, Catalent, Inc., Wuxi Biologics.

Asia Pacific Biologics Contract Manufacturing Market: Segmentation

Asia Pacific Biologics Contract Manufacturing Market, by Type

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Molecular Therapy
  • Others

Asia Pacific Biologics Contract Manufacturing Market, by Region

  • Asia Pacific
    • Japan
    • South Korea
    • Taiwan
    • Singapore
    • Thailand
    • India
    • Rest of Asia Pacific

About Us

Transparency Market Research is a market intelligence company, providing business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

7 of 10 large enterprizes view our ToC to take the right decision.

View Report ToC